Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
Robert L. Stout, Steven J. Rigatti
Abstract
This cross-sectional study of a sample of healthy adults assesses the seroprevalence of SARS-CoV-2 antibodies in the US asymptomatic population as of September 30, 2020.
Topics & Concepts
SeroprevalenceAsymptomaticSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAntibodyPopulationSerologyImmunologyEnvironmental healthInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing